Skip to main content

Table 5 Medication used in the CAA population before and after CAA diagnosis

From: Prescribing patterns of coronary artery aneurysm in Taiwan

 

Before index date

After index date

1 year

3 month

6 month

1 year

N = 811

N (%)

N (%)

N (%)

N (%)

Antithrombotic agent

555 (68.4)

680 (83.8)

700 (86.3)

722 (89.0)

 Aspirin

477 (58.8)

568 (70.0)

587 (72.4)

615 (75.8)

 Clopidogrel

163 (20.1)

329 (40.6)

338 (41.7)

351 (43.3)

 Dipyridamole

34 (4.2)

12 (1.5)

22 (2.7)

31 (3.8)

 Cilostazol

13 (1.6)

18 (2.2)

20 (2.5)

29 (3.6)

 Ticlopidine

12 (1.5)

10 (1.2)

16 (2.0)

20 (2.5)

 Warfarin

33 (4.1)

76 (9.4)

97 (12.0)

109 (13.4)

Antihypertensive agent

599 (73.9)

613 (75.6)

675 (83.2)

703 (86.7)

 ACEI

161 (19.9)

144 (17.8)

163 (20.1)

181 (22.3)

 ARBs

234 (28.9)

229 (28.2)

261 (32.2)

300 (37.0)

 CCBs

348 (42.9)

283 (34.9)

324 (40.0)

371 (45.7)

 β-blockers

289 (35.6)

197 (24.3)

314 (38.7)

392 (48.3)

 Diuretics

171 (21.1)

181 (22.3)

210 (25.9)

237 (29.2)

 α-blockers

116 (14.3)

76 (9.4)

105 (12.9)

129 (15.9)

Antidyslipidemic agents

291 (35.9)

321 (39.6)

370 (45.6)

410 (50.6)

 Statins

257 (31.7)

300 (37.0)

349 (43.0)

386 (47.6)

 Fibrates

53 (6.5)

24 (3.0)

31 (3.8)

50 (6.2)

 Others

11 (1.4)

13 (1.6)

14 (1.7)

18 (2.2)

Antidiabetic agents

177 (21.8)

144 (17.8)

170 (21.0)

187 (23.1)

 Metformin

114 (14.1)

79 (9.7)

96 (11.8)

117 (14.4)

 Sulfonylureas

132 (16.3)

98 (12.1)

107 (13.2)

117 (14.4)

 Thiazolidinedione (TZD)

43 (5.3)

23 (2.8)

31 (3.8)

33 (4.1)

 DDP-4 inhibitors

10 (1.2)

10 (1.2)

16 (2.0)

23 (2.8)

 Others

45 (5.5)

28 (3.5)

38 (4.7)

49 (6.0)

Nitrates

265 (32.7)

290 (35.8)

350 (43.2)

388 (47.8)

 Nitroglycerin

43 (5.3)

11 (1.4)

27 (3.3)

74 (9.1)

 Isosorbide dinitrate

57 (7.0)

58 (7.2)

75 (9.2)

86 (10.6)

 Isosorbide mononitrate

184 (22.7)

216 (26.6)

246 (30.3)

267 (32.9)

 Nicorandil

41 (5.1)

24 (3.0)

44 (5.4)

69 (8.5)

  1. ACEI angiotensin-converting-enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker, TZD thiazolidinedione, DDP-4 inhibitor dipeptidyl peptidase-4 inhibitor